Zubair Ahmed
Neurology · Cleveland, OHNPI 1801185368
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (48.8%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 12 manufacturers reported payments, led by AbbVie at 42.2% of the total. Reporting peaked in 2020 at $35,813 and has fallen 99.3% since, to $251 in 2025. Among neurology clinicians in OH with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 149 payments — averaging $694.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$44K
- Eli Lilly$40K
- Supernus Pharmaceuticals, Inc.$5K
- Biohaven Pharmaceutical Holding Company Ltd.$5K
- Lundbeck LLC$3K
- Amgen$3K
- plus $3K from 6 others
Across 33 payments — averaging $17,985 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Teva Pharmaceuticals USA, Inc.$303K
- Amgen$235K
- H. Lundbeck A S$55K
What the payments were for
- Consulting fees$25,97525%
- Speaking & faculty fees$50,51549%
- Travel & lodging$24,23523%
- Food & beverage$2,8053%
- Education$190%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 58 | $43,736 |
| Eli Lilly | 47 | $39,610 |
| Supernus Pharmaceuticals, Inc. | 9 | $5,229 |
| Biohaven Pharmaceutical Holding Company Ltd. | 7 | $5,073 |
| Lundbeck LLC | 7 | $3,386 |
| Amgen | 4 | $3,091 |
| Lilly USA, LLC | 9 | $2,323 |
| Biogen | 1 | $900 |
| Stryker | 1 | $76 |
| Teva Pharmaceuticals USA, Inc. | 2 | $69 |
| Biohaven Pharmaceuticals, Inc. | 3 | $43 |
| Almatica Pharma LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- UBRELVY$40,619
- EMGALITY$7,171
- TROKENDI XR$5,133
- NURTEC ODT$5,000
- VYEPTI$3,103
- AIMOVIG$3,000
- QULIPTA$1,800
- BOTOX$375
How this compares
$103,550 in reported general payments places this provider in the 90th percentile of 702 neurology providers in Ohio.
Other neurology in Cleveland
- Imad NajmCleveland$373K
- Hesham AbboudCleveland$363K
- Robert BermelCleveland$302K
- Eric BaronCleveland$297K
- Robert FoxCleveland$296K
- Aarushi SunejaCleveland$269K
- Mary WillisCleveland$254K
- Benjamin WalterCleveland$210K
- Aasef ShaikhCleveland$186K
- Maryann MaysCleveland$173K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.